In conclusion, these findings suggest that Shh-positive MPs could represent a potent tool for stimulating NO release and reducing oxidative stress in the vessel wall to completely reverse Ang II-induced hypertension and extend the use of such MPs to treated disease states associated with endothelial dysfunction in addition to those associated with impaired angiogenesis. This evidence concerns the gene SHH and endothelial dysfunction.